Product NDC: | 49252-001 |
Proprietary Name: | Metformin hydrochloride |
Non Proprietary Name: | Metformin hydrochloride |
Active Ingredient(s): | 500 mg/1 & nbsp; Metformin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49252-001 |
Labeler Name: | Inventia Healthcare Private Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA201991 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120601 |
Package NDC: | 49252-001-17 |
Package Description: | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (49252-001-17) |
NDC Code | 49252-001-17 |
Proprietary Name | Metformin hydrochloride |
Package Description | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (49252-001-17) |
Product NDC | 49252-001 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Metformin hydrochloride |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20120601 |
Marketing Category Name | ANDA |
Labeler Name | Inventia Healthcare Private Limited |
Substance Name | METFORMIN HYDROCHLORIDE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Biguanide [EPC],Biguanides [Chemical/Ingredient] |